deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT04819269

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

Sponsor: Sylentis, S.A.

Updated 12 times since 2021 Last updated: Feb 16, 2024 Started: May 25, 2021 Primary completion: Dec 11, 2023 Completion: Dec 11, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Dry Eye Disease and Sjögren Syndrome and is currently completed. Sylentis, S.A. leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2021 – ~May 2021 · 30 days · monthly snapshotNot Yet Recruiting~May 2021 – ~Jun 2021 · 31 days · monthly snapshotNot Yet Recruiting~Jun 2021 – ~Oct 2021 · 4 months · monthly snapshotRecruiting~Oct 2021 – ~Apr 2022 · 6 months · monthly snapshotRecruiting~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshotRecruiting~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotRecruiting~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshotRecruiting~Mar 2023 – ~Mar 2024 · 12 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE3

    Status: RecruitingCompleted

  5. Mar 2023 — Mar 2024 [monthly]

    Recruiting PHASE3

Show 7 earlier versions
  1. Sep 2022 — Mar 2023 [monthly]

    Recruiting PHASE3

  2. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE3

  3. Apr 2022 — Jul 2022 [monthly]

    Recruiting PHASE3

  4. Oct 2021 — Apr 2022 [monthly]

    Recruiting PHASE3

  5. Jun 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  6. May 2021 — Jun 2021 [monthly]

    Not Yet Recruiting PHASE3

  7. Apr 2021 — May 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sylentis, S.A.
Data source: Sylentis, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .